Related Experiment Video

Updated: Jun 3, 2026

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias

P Vitali1, E Maccagnano, E Caverzasi

  • 1Department of Neurology, Memory & Aging Center, University of California, San Francisco, San Francisco, CA 94143-1207, USA.

Neurology
|April 8, 2011
PubMed
Abstract

Insights

Magnetic Resonance Imaging (MRI) using Diffusion-Weighted Imaging (DWI) and fluid-attenuated inversion recovery (FLAIR) can accurately distinguish Creutzfeldt-Jakob disease (CJD) from other rapidly progressive dementias. This MRI pattern offers high sensitivity and specificity for diagnosing sporadic CJD.

Area of Science:

  • Neurology
  • Radiology
  • Neuroimaging

Background:

  • Diffusion-weighted imaging (DWI) and FLAIR MRI are sensitive for Creutzfeldt-Jakob disease (CJD).
  • Distinguishing CJD from nonprion rapidly progressive dementias (npRPD) using MRI remains a challenge.
  • This study aimed to evaluate MRI's diagnostic accuracy for CJD versus npRPD.

Purpose of the Study:

  • To determine the diagnostic accuracy of MRI, specifically DWI and FLAIR sequences, in differentiating sporadic CJD (sCJD) from npRPD.
  • To identify specific MRI patterns indicative of sCJD.
  • To propose updated MRI criteria for sCJD diagnosis.

Main Methods:

  • Two blinded neuroradiologists reviewed DWI and FLAIR MRI scans from 90 patients (29 npRPD, 48 sCJD, 13 genetic prion disease).
  • Abnormal hyperintensities were assessed in 31 gray matter regions per hemisphere.
  • The likelihood of CJD was determined using established criteria.

Main Results:

  • All sCJD cases exhibited gray matter hyperintensities (DWI > FLAIR), with characteristic regional involvement.
  • Restricted diffusion (ADC map) was present in basal ganglia/thalamic DWI hyperintensities in sCJD, but absent in npRPD.
  • npRPD cases commonly showed isolated limbic hyperintensities (FLAIR > DWI).
  • Combined MRI sensitivity and specificity for sCJD reached 96% and 93% after consensus review.

Conclusions:

  • The pattern of FLAIR/DWI hyperintensity and restricted diffusion effectively differentiates sCJD from other rapidly progressive dementias (RPDs).
  • MRI, including DWI and apparent diffusion coefficient (ADC) mapping, should be integral to sCJD diagnostic criteria.
  • New MRI criteria for sCJD diagnosis are proposed based on these findings.

More Related Videos

Diffusion Tensor Magnetic Resonance Imaging in Chronic Spinal Cord Compression07:00

Diffusion Tensor Magnetic Resonance Imaging in Chronic Spinal Cord Compression

Published on: May 7, 2019

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Related Concept Videos

Assessment of Diffusion and Perfusion01:17

Assessment of Diffusion and Perfusion

Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this principle...
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...